Research on messenger RNA technology is being explored for its potential in cancer therapeutics, with developments extending beyond its use in covid-19 vaccines. The technology is being investigated for its applications in various types of cancer, including colorectal and lung cancer. The market for mRNA therapeutics is projected to grow, with estimated values ranging from $20.99 billion to $45.04 billion by 2034.